I’ve tried everything,” Dr. Nathaniel Chin, an associate professor at the University of Wisconsin Department of Medicine, told The Post.

Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart health, reduce infections, lower substance abuse risks, and even decrease the chance of dementia.

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist.

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease and psychotic disorders.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia,

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health outcomes. View on euronews

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal Alzheimer's and Dementia: Translational Research & Clinical Interventions .

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are linked to reduced risks of dementia, heart failure, and severe infections, according to a study involving over 2 million patients. However, these weight-loss and diabetes drugs also pose risks,